{"id":"changkang-granules","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL564","moleculeType":"Small molecule","molecularWeight":"284.43"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The granules contain herbal ingredients traditionally used to enhance intestinal peristalsis and regulate gastrointestinal function. It is designed to address functional gastrointestinal disorders by promoting normal bowel movement and digestive processes through multi-component herbal synergy.","oneSentence":"Changkang granules is a traditional Chinese medicine formulation that promotes gastrointestinal motility and improves digestive function.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:43.564Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Functional constipation"},{"name":"Gastrointestinal motility disorders"}]},"trialDetails":[{"nctId":"NCT06753890","phase":"PHASE3","title":"Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)","status":"NOT_YET_RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2024-12-30","conditions":"Diarrhea-predominant Irritable Boewl Syndrome","enrollment":520},{"nctId":"NCT04492787","phase":"PHASE2","title":"Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2020-07-06","conditions":"Irritable Bowel Syndrome with Diarrhea","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Changkang granules","genericName":"Changkang granules","companyName":"Tasly Pharmaceutical Group Co., Ltd","companyId":"tasly-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Changkang granules is a traditional Chinese medicine formulation that promotes gastrointestinal motility and improves digestive function. Used for Functional constipation, Gastrointestinal motility disorders.","enrichmentLevel":3,"visitCount":3,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}